Amlodipine And Valsartan
Product Images NDC 45865-880

Product Visual Gallery

This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Amlodipine And Valsartan (NDC 45865-880). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Medsource Pharmaceuticals, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Pdp (880)

Amlodipine and Valsartan tablets 5 mg / 160 mg rectangular label from Medsource Pharmaceuticals. The generic product is for Exforge, distributed by Lyphin Ltd. The label includes dosing instructions, a caution about dizziness, and advises against use in pregnancy. The package contains 100 film-coated tablets.*

FDA Label Image

Image-01 (B5a13389 E39e 4825 A6dc 4ba50d432aed 01)

A line graph comparing the percentage of patients achieving systolic blood pressure (SBP) below 140 mmHg against baseline SBP levels (140 to 180 mmHg) for different treatments: Amlodipine and Valsartan Tablets 10/320 mg, Valsartan 320 mg, Amlodipine 10 mg, and placebo. Each treatment is represented by distinct symbols, showing decreasing trends as baseline SBP increases.*

FDA Label Image

Image-02 (B5a13389 E39e 4825 A6dc 4ba50d432aed 02)

A line graph depicting the percentage of patients with diastolic blood pressure (DBP) under 90 mmHg over a range of blood pressure values from 95 to 110. The graph compares four groups: Amlodipine and Valsartan combination tablets (10/320 mg), Valsartan 320 mg alone, Amlodipine 10 mg alone, and placebo. Each group is represented by distinct symbols showing the trend of DBP control across the blood pressure range.*

FDA Label Image

Image-03 (B5a13389 E39e 4825 A6dc 4ba50d432aed 03)

A line graph comparing the percentage of patients achieving systolic blood pressure (SBP) below 130 mmHg against baseline SBP values, for different treatments: Amlodipine and Valsartan combination tablets (10/320 mg), Valsartan 320 mg, Amlodipine 10 mg, and placebo. The treatments are represented by different symbols and show a descending trend as baseline SBP increases.*

FDA Label Image

Image-04 (B5a13389 E39e 4825 A6dc 4ba50d432aed 04)

A line graph comparing the percentage of diastolic blood pressure (DBP) less than 80 mmHg against baseline DBP (mmHg) for four treatment groups: Amlodipine and Valsartan tablets 10/320 mg, Valsartan 320 mg, Amlodipine 10 mg, and placebo. The graph includes a legend identifying each group's symbol.*

FDA Label Image

Amlodipineandvals-figure-01 (B5a13389 E39e 4825 A6dc 4ba50d432aed 05)

Chemical structure diagram showing two molecules: one complex organic molecule with a chlorine atom, an ester group, and an amine side chain, and a second molecule containing a benzene ring with a sulfonic acid group. The image likely represents the active ingredients in Amlodipine and Valsartan by medsource pharmaceuticals.*

FDA Label Image

Amlodipineandvals-figure-02 (B5a13389 E39e 4825 A6dc 4ba50d432aed 06)

Chemical structure of the active ingredient for Amlodipine and Valsartan from medsource pharmaceuticals, showing molecular bonds and atoms arrangement.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.